Ingrid A. Binswanger, MD, MPH, MS

Senior Clinician Investigator

Ingrid A. Binswanger, MD, MPH, MS, is a Senior Clinician Investigator at the Institute for Health Research. Her research focuses on how to reduce the medical complications of substance use, such as overdose and HIV.

Dr. Binswanger completed her medical training at the University of California, San Francisco and received her Master of Public Health degree from the University of Washington, Seattle. Her research team is working to develop innovative and patient-centered ways to prevent adverse events from opioid use. She also conducts research to reduce the morbidity and mortality of people who have criminal justice involvement.

Dr. Binswanger is a practicing physician in Chemical Dependency Treatment Services with the Colorado Permanente Medical Group at Kaiser Permanente Colorado. She is also an Associate Professor in the Division of General Internal Medicine and an Affiliate Member of the Division of Substance Dependence at the University of Colorado School of Medicine. She is an Adjunct Professor of Health Systems Science at the Bernard J. Tyson Kaiser Permanente School of Medicine. She is a Senior Editor of the journal Addiction.

Selected Research:

  • Coronavirus Disease 2019 (COVID-19) Testing in Colorado: A Prospective Cohort in Kaiser Permanente Colorado
  • The goal of this study is to conduct a research-operations partnership strategy to generate timely data to better understand the critical epidemiological characteristics of the novel SARS-CoV-2 via surveys and viral and antibody testing. 

    • Funder: Garfield Memorial Fund
    • Award End Date: 05/31/2020

  • Determining the Optimal Duration of Buprenorphine Treatment to Reduce the Risk of Relapse, Overdose, and Mortality
  • The purpose of this study is to use a prescription opioid registry containing EHR data across nine diverse health systems to assess how different lengths of buprenorphine retention are related to mortality.

    • Funder: National Institute on Drug Abuse
    • Award End Date: 05/31/2021

  • The Safety and Impact of Expanded Access to Naloxone in Health Systems
  • This study examines the impact and safety of expanded access to naloxone, an effective opioid antidote which reverses opioid overdose, for patients prescribed opioids for pain in two large and diverse health systems.

    • Funder: National Institute on Drug Abuse
    • Award End Date: 04/30/2022

  • Assessing the Safety and Effectiveness of Opioid Tapering in Large Health Systems
  • The major goal of this project is to conduct a longitudinal cohort study to determine the effectiveness and safety of opioid tapering in three large health systems in two states.

    • Funder: National Institute on Drug Abuse
    • Award End Date: 12/31/2022

  • Integrating Addiction Research in Health Systems: The Addiction Research Network
  • This project brings together 16 Health Care Systems Research Network member health systems to conduct research focused on all aspects of addiction.

    • Funder: National Institute on Drug Abuse
    • Study End Date: 02/28/2025